Utah Medical Products, Inc.
This article was originally published in The Gray Sheet
Executive Summary
Shareholders tender approximately 1.3 mil. shares under an $8-per-share repurchase offer announced May 26 (1"The Gray Sheet" May 31, p. 20). UM will purchase about 1.15 mil. of the shares "in accordance with the applicable regulations of the SEC, which allow the company to purchase pursuant to the offer an additional amount of shares not to exceed 2% of UM's outstanding shares," the firm explains. About 6.5 mil. shares will be outstanding after the repurchase. "Shareholders who did not tender their shares now own 18% more of UM than they did before the offer expired" July 23, the Salt Lake City firm says